Cyclodextrin Technologies Development Inc.

CyDex Pharmaceuticals Receives U.S. Patent for New Captisol[R].
Business Wire; 12/9/2009; 963 words; ...Pharmaceuticals, Inc., a specialty...Sulfoalkyl Ether Cyclodextrin Compositions and...previously issued technology patents, will provide...agglomerated beta cyclodextrin sulfobutyl ether...Pharmaceuticals, Inc. "These improved...supporting drug development efforts with more...

CyDex Series B Nets $17M For Internal Drug Programs.
BIOWORLD Today; 11/3/2009; 1215 words; ...Staff Writer CyDex Inc. raised $17 million...license for further development. Through a couple...on its delivery technology, Captisol, which...marketed by Pfizer Inc. - and a dozen...Captisol, a modified cyclodextrin for use in drug...Pharmaceuticals Inc., of Melville...

Calando To Use Alnylam's RNAi Portfolio For Cancer.
BIOWORLD Today; 11/3/2009; 885 words; ...Pharmaceuticals Inc. to develop an...toward preclinical development is an unmodified...Calando's delivery technology was licensed from...Insert Therapeutics Inc., also a majority...described as a linear cyclodextrin polymer combined...Sirna Therapeutics Inc. - that hold much...

CIT, EXK, NCS, ARWR, TPI, TBHS Have Been Added To Naked Short Lists Today.
M2 Presswire; 10/14/2009; 2559 words; ...net. CIT Group Inc. (NYSE: CIT...exploration, development, and exploitation...Building Systems, Inc. (NYSE: NCS...Building Systems, Inc. was founded in...delivery platform technology based on a nano...class of linear cyclodextrin-containing polymers...

CyDex Pharmaceuticals Extends Agreement with Hovione.
Biotech Week; 10/7/2009; 801 words; ...Pharmaceuticals, Inc. CyDex Pharmaceuticals, Inc. is a specialty...Captisol[R] technology. Captisol...supporting drug development efforts with...Captisol and cyclodextrin technologies, and a comprehensive...Pharmaceuticals Inc. This article...